Joseph Hargett

Joseph Hargett

InvestorPlace Contributor

Despite hailing from the Greater Cincinnati, Ohio area, Joseph Hargett has spent nearly the past decade elbow-deep in Wall Street.  Specializing in financial writing, options strategies and stock-market analysis, Joseph cut his teeth in the research department of Cincinnati-based Schaeffer’s Investment Research.

While at Schaeffer’s, Joseph wrote market, stock and options commentary for SchaeffersResearch.com, and was lead editor for The Options Advisor (the nation’s leading options newsletter).

Joseph has since moved on to become a prolific Forbes contributor in the options realm, as well as a lead copy editor and contributor for a well respected investment newsletter publisher.  Joseph’s commentary has appeared in a plethora of media outlets, including The Wall Street Journal, The New York Times, Money Show Digest, Reuters, CBE MarketWatch and Sentiment Magazine.

Recent Articles

Take the Long View on Canopy Growth’s Potential

By Joseph Hargett, InvestorPlace Contributor

Canopy Growth is mellowing out after Constellation's $4 billion buy-in. But cannabis stocks are still volatile, so here are two ways to trade CGC stock.

Friday’s Vital Data: Apple, Amazon and Advanced Micro Devices

By Joseph Hargett, InvestorPlace Contributor

AAPL and AMZN options rallied on bullish analyst activity. On the other hand AMD was downgraded at Northland.

Under Armour Stock Is Sprinting Higher — Trade the Breakout

By Joseph Hargett, InvestorPlace Contributor

Under Armour stock is sprinting higher on rising consumer demand and an improving economy. It's time to bet bullish on UAA ahead of earnings.

Thursday’s Vital Data: Square, Netflix and Fortive

By Joseph Hargett, InvestorPlace Contributor

SQ call options rose after a price target hike. NFLX rallied on an industry subscriptions report. FTV was flooded amid its unit sale to Altra.

Earnings Preview: Playing the Long Game with Constellation Brands Stock

By Joseph Hargett, InvestorPlace Contributor

Laying out $4 billion for Canopy Growth (CGC) could hurt Constellation Brands short-term earnings outlook. But with a $200 billion global market on the line, investors should buy the dip in STZ stock.

Wednesday’s Vital Data: Advanced Micro Devices, Square and Nike

By Joseph Hargett, InvestorPlace Contributor

Options traders backed away from Advanced Micro (AMD). Nomura is bullish on Square (SQ). Nike (NKE) earnings disappoint.

Carnival Stock Faces Choppy Waters Ahead of Earnings

By Joseph Hargett, InvestorPlace Contributor

Wall Street is expecting an earnings beat from Carnival this Thursday. Guidance will be key for CCL stock, but will consumer pressures and rising fuel prices scuttle a post-earnings rally?

Tuesday’s Vital Data: General Electric Company, Snap and Amarin

By Joseph Hargett, InvestorPlace Contributor

GE options jumped as it hit a 9-year low. Snap signed a deal with Amazon, and Amarin skyrocketed on a fish oil capsule trial.

Nike Earnings: Millennials Vs. China Tariffs, Who Will Win?

By Joseph Hargett, InvestorPlace Contributor

Nike earnings face a showdown between Millennial spending and Chinese tariffs. With NKE stock near overbought levels, it will take strong guidance to push Nike shares higher along their current rally.

Monday’s Vital Data: Apple, Micron and Transocean

By Joseph Hargett, InvestorPlace Contributor

AAPL options were divided as new iPhone hit store shelves, and MU saw mixed activity following poor guidance. RIG was put heavy following a new contract.

Load More